All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ARIDIS PHARMACEUTICALS, INC. Last Reported: 12/31/2023 Stock Symbol: ARDS

Business Address

983 UNIVERSITY AVENUE, BLDG. B

LOS GATOS , CA US 95032

Mailing Address

983 UNIVERSITY AVENUE, BLDG. B

LOS GATOS , CA US 95032
Phone Number: (408) 385-1742 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 9/30/2022 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash and Cash Equivalents $35,000.00 $1,886,000.00 $18,221,000.00 $3,592,000.00 $8,232,000.00 $6,200,000.00 $11,812,000.00 $16,324,000.00 $20,900,000.00 $17,330,000.00 $8,519,000.00 $16,311,000.00 $24,237,000.00 $34,077,000.00 $13,470,000.00 -- $25,096,000.00 -- --
Accounts Receivable Net Current $400,000.00 -- $1,000,000.00 -- -- -- $1,000,000.00 -- -- -- $1,000,000.00 -- $1,660,000.00 $800,000.00 -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $3,558,000.00 $3,768,000.00 $2,177,000.00 $3,229,000.00 $2,182,000.00 $2,287,000.00 $1,441,000.00 $1,848,000.00 $2,990,000.00 $3,159,000.00 $2,390,000.00 $2,058,000.00 $2,012,000.00 $1,405,000.00 $960,000.00 -- $244,000.00 -- --
Total Current Assets $4,110,000.00 $8,635,000.00 $23,581,000.00 $8,937,000.00 $12,755,000.00 $10,194,000.00 $16,148,000.00 $19,976,000.00 $25,837,000.00 $31,090,000.00 $13,357,000.00 $20,511,000.00 $28,347,000.00 $36,282,000.00 $14,430,000.00 -- $25,340,000.00 -- --
Property Plant and Equipement $511,000.00 $974,000.00 $1,446,000.00 $1,367,000.00 $1,258,000.00 $779,000.00 $845,000.00 $923,000.00 $1,006,000.00 $1,075,000.00 $1,135,000.00 $1,190,000.00 $1,271,000.00 $1,231,000.00 $1,280,000.00 -- $750,000.00 -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $327,000.00 $383,000.00 $433,000.00 $475,000.00 $487,000.00 $587,000.00 $572,000.00 $557,000.00 $557,000.00 $2,118,000.00 $1,015,000.00 $995,000.00 $995,000.00 $41,000.00 $345,000.00 -- $345,000.00 -- --
Total Assets $6,534,000.00 $12,120,000.00 $26,085,000.00 $11,387,000.00 $15,117,000.00 $12,106,000.00 $18,115,000.00 $22,007,000.00 $27,967,000.00 $34,367,000.00 $15,874,000.00 $23,250,000.00 $31,611,000.00 $38,573,000.00 $16,096,000.00 -- $26,478,000.00 -- --
Accounts Payable $5,410,000.00 $4,230,000.00 $2,644,000.00 $2,464,000.00 $1,886,000.00 $1,219,000.00 $1,696,000.00 $1,967,000.00 $1,755,000.00 $3,125,000.00 $1,544,000.00 $2,716,000.00 $2,331,000.00 $1,760,000.00 $610,000.00 -- $933,000.00 -- --
Accrued Liabilities $7,691,000.00 $8,494,000.00 $6,560,000.00 $1,851,000.00 $1,330,000.00 $1,865,000.00 $2,175,000.00 $2,815,000.00 $2,974,000.00 $2,863,000.00 $3,468,000.00 $1,825,000.00 $2,944,000.00 $4,890,000.00 $2,330,000.00 -- $2,121,000.00 -- --
Total Current Liabilities $18,336,000.00 $47,943,000.00 $30,240,000.00 $24,874,000.00 $23,798,000.00 $23,404,000.00 $24,189,000.00 $24,384,000.00 $24,331,000.00 $25,590,000.00 $5,012,000.00 $4,541,000.00 $5,297,000.00 $7,203,000.00 $13,914,000.00 -- $15,042,000.00 -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $7,787,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-190,421,000.00 $-189,279,000.00 $-156,485,000.00 $-135,483,000.00 $-123,102,000.00 $-117,279,000.00 $-111,493,000.00 $-107,273,000.00 $-100,769,000.00 $-95,121,000.00 $-87,534,000.00 $-79,151,000.00 $-71,088,000.00 $-65,649,000.00 $-57,735,000.00 -- $-47,626,000.00 -- --
Total Stockholders' Equity $-11,802,000.00 $-35,823,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $6,534,000.00 $12,120,000.00 $26,085,000.00 $11,387,000.00 $15,117,000.00 $12,106,000.00 $18,115,000.00 $22,007,000.00 $27,967,000.00 $34,367,000.00 $15,874,000.00 $23,250,000.00 $31,611,000.00 $38,573,000.00 $16,096,000.00 -- $26,478,000.00 -- --

Statement of Operations

Date 9/30/2023 9/30/2022 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $10,374,000.00 $18,916,000.00 $19,842,000.00 $9,528,000.00 $16,956,000.00 $4,161,000.00 $3,647,000.00 $4,917,000.00 $24,083,000.00 $19,782,000.00 $6,653,000.00 $7,118,000.00 $23,000,000.00 $17,418,000.00 $3,885,000.00 $6,626,000.00 $17,438,000.00 $12,836,000.00 $3,170,000.00
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $14,609,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-869,000.00 $-22,573,000.00 $-34,159,000.00 $-13,133,000.00 $-22,401,000.00 $-16,578,000.00 $-4,230,000.00 $-6,556,000.00 $-29,087,000.00 $-23,398,000.00 $-16,003,000.00 $-7,737,000.00 $-24,117,000.00 $-6,620,000.00 $-11,920,000.00 $-7,370,000.00 $-19,738,000.00 $-5,486,000.00 $-3,977,000.00
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $0.15 $-0.47 -- -- -- -- -- -- -- $-2.89 $-1.03 $-0.99 $-7.45 $-1.97 $-60.76 $-48.99 $-164.98 $-130.65 $-40.77
Weighted Average Shares Basic 37,428,943 17,701,592 -- -- -- -- -- -- -- 8,694,104 8,107,290 8,105,636 3,146,632 1,469,623 166,373 166,373 166,373 166,373 166,373
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- $-2.89 $-2.03 $-0.99 $-7.45 $-1.97 $-60.76 $-48.99 $-164.98 $-130.65 $-93.35
Weighted Average Shares Diluted 47,178,967 -- -- -- -- -- -- -- -- 8,694,104 8,107,290 8,105,636 3,146,632 4,019,459 166,373 166,373 166,373 166,373 166,373
Common Stock Shares Authorized 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 -- 100,000,000 -- --
Common Stock Shares Outstanding 44,574,021 17,701,592 14,054,036 11,234,480 10,065,727 8,923,374 8,923,374 8,923,374 8,918,461 8,912,227 8,107,290 8,107,290 8,104,757 8,103,783 166,373 -- 166,373 -- --
Common Stock Value $5,000.00 $2,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 60,000,000 60,000,000 60,000,000 60,000,000 60,000,000 60,000,000 60,000,000 60,000,000 60,000,000 -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com